Business
Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine
Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine

About this update from Changchun Bcht Biotechnology Co. Class A
Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment
View stock analysis, news, and events for Changchun Bcht Biotechnology Co. Class A